4//SEC Filing
Oki Mark K 4
Accession 0000950170-25-042074
CIK 0000949858other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:38 PM ET
Size
5.2 KB
Accession
0000950170-25-042074
Insider Transaction Report
Form 4
Oki Mark K
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-03-17$2.89/sh+10,000$28,887→ 10,000 total
Footnotes (1)
- [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.85 to $2.9387 per share, inclusive. The Rreporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
ACHIEVE LIFE SCIENCES, INC.
CIK 0000949858
Entity typeother
Related Parties
1- filerCIK 0001491847
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:38 PM ET
- Size
- 5.2 KB